Spiering W - Search Results

1

The combined use of aspirin, a statin, and blood pressure-lowering agents (polypill components) and the risk of vascular morbidity and mortality in patients with coronary artery disease.

Lafeber M, Spiering W, van der Graaf Y, Nathoe H, Bots ML, Grobbee DE, Visseren FL. Lafeber M, et al. Among authors: spiering w. Am Heart J. 2013 Aug;166(2):282-289.e1. doi: 10.1016/j.ahj.2013.04.011. Epub 2013 Jun 15. Am Heart J. 2013. PMID: 23895811

2

[Sensory disturbances caused by multivitamin preparations].

Spiering W, Visseren FL. Spiering W, et al. Ned Tijdschr Geneeskd. 2006 Feb 4;150(5):277; author reply 277. Ned Tijdschr Geneeskd. 2006. PMID: 16494000 Dutch. No abstract available.

3

[Infection-induced vascular disease: little evidence according to the Koch's postulates].

Visseren FL, Spiering W, Hoepelman IM. Visseren FL, et al. Among authors: spiering w. Ned Tijdschr Geneeskd. 2007 Dec 29;151(52):2883-7. Ned Tijdschr Geneeskd. 2007. PMID: 18257433 Review. Dutch.

4

Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients.

Vlek AL, van der Graaf Y, Spiering W, Visseren FL; SMART study group. Vlek AL, et al. Among authors: spiering w. J Hum Hypertens. 2008 May;22(5):358-65. doi: 10.1038/jhh.2008.5. Epub 2008 Feb 14. J Hum Hypertens. 2008. PMID: 18273039

5

Cardiovascular events and all-cause mortality by albuminuria and decreased glomerular filtration rate in patients with vascular disease.

Vlek AL, van der Graaf Y, Spiering W, Algra A, Visseren FL; SMART study group. Vlek AL, et al. Among authors: spiering w. J Intern Med. 2008 Oct;264(4):351-60. doi: 10.1111/j.1365-2796.2008.01970.x. Epub 2008 Jun 3. J Intern Med. 2008. PMID: 18522685 Free article.

6

Metabolic syndrome and incidence of type 2 diabetes in patients with manifest vascular disease.

Wassink AM, Van Der Graaf Y, Soedamah-Muthu SS, Spiering W, Visseren FLj; Smart Study Group. Wassink AM, et al. Among authors: spiering w. Diab Vasc Dis Res. 2008 Jun;5(2):114-22. doi: 10.3132/dvdr.2008.019. Diab Vasc Dis Res. 2008. PMID: 18537099 Free article.

7

Differences in determinants of left ventricular mass assessed by cardiac magnetic resonance imaging across subjects with and without previous symptomatic atherosclerotic disease.

Meijs MF, Bots ML, Cramer MJ, Vonken EJ, Velthuis BK, van der Graaf Y, Spiering W, Mali WP, Doevendans PA; SMART Study group. Meijs MF, et al. Among authors: spiering w. Int J Cardiol. 2010 Jan 21;138(2):145-50. doi: 10.1016/j.ijcard.2008.08.008. Epub 2008 Sep 19. Int J Cardiol. 2010. PMID: 18804881

8

Vascular and metabolic effects of 12 days intensive walking to Santiago de Compostela.

Bemelmans RH, Coll B, Faber DR, Westerink J, Blommaert PP, Spiering W, Visseren FL. Bemelmans RH, et al. Among authors: spiering w. Atherosclerosis. 2010 Oct;212(2):621-7. doi: 10.1016/j.atherosclerosis.2010.06.012. Epub 2010 Jun 11. Atherosclerosis. 2010. PMID: 20598693

9

[Obesity-related hypertension].

Dorresteijn JA, Visseren FL, van den Meiracker AH, Spiering W. Dorresteijn JA, et al. Among authors: spiering w. Ned Tijdschr Geneeskd. 2011;154:A1945. Ned Tijdschr Geneeskd. 2011. PMID: 21418695 Review. Dutch.

10

Relation between thyroid-stimulating hormone and the occurrence of cardiovascular events and mortality in patients with manifest vascular diseases.

Westerink J, van der Graaf Y, Faber DR, Spiering W, Visseren FL; SMART study group. Westerink J, et al. Among authors: spiering w. Eur J Prev Cardiol. 2012 Aug;19(4):864-73. doi: 10.1177/1741826711416045. Epub 2011 Jul 1. Eur J Prev Cardiol. 2012. PMID: 21724680

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

211 results

Search Page